Maureen is a litigation partner who concentrates her practice on patent infringement, particularly in the area of pharmaceutical patent litigation, as well as other complex commercial matters. She also has extensive experience and knowledge in antitrust issues related to patent enforcement and settlement. Maureen has represented a number of pharmaceutical companies in patent litigation, antitrust litigation, and FDA matters. Since 2001, Maureen’s practice has centred primarily on pharmaceutical patent litigation under the Hatch-Waxman Act, as well as regulatory issues involved in obtaining FDA approval for generic drugs and biosimilars. Maureen has also worked extensively on appellate matters, including working on several Federal Circuit appeals involving patent litigation, a Second Circuit appeal, and a petition for certiorari in the tamoxifen matter, and fully briefing and successfully arguing a habeas corpus appeal before the Seventh Circuit. Since 2017, Maureen has been recognized by IAM Patent 1000 – World’s Leading Patent Professionals as “a great courtroom trial lawyer” and “a rising star to keep your eye on.” She is also a 2019 LMG Life Sciences Star.
